Recombinant Human D266N Protein，His

The D266N recombinant protein has garnered attention in the fields of molecular biology and biochemistry due to its potential implications in understanding disease mechanisms and therapeutic development. This protein variant is a specific mutation in the gene encoding for a target enzyme or receptor, which is often linked to various pathological conditions. Research into the D266N mutation aims to unravel its effects on protein structure, function, and stability, as mutations in critical residues can lead to altered enzymatic activity or disrupted interactions with other biomolecules. Such studies are crucial for elucidating the biological roles of this protein and its involvement in metabolic pathways or signaling cascades. Additionally, the recombinant expression of D266N allows for the investigation of its properties in vitro, enabling researchers to assess how this specific alteration can influence drug binding or the efficacy of therapeutic agents. Understanding the functional consequences of the D266N mutation can contribute to the development of targeted treatments, personalized medicine approaches, and the discovery of biomarkers for disease diagnosis and prognosis. Furthermore, the study of this recombinant protein can provide insights into broader biological processes, highlighting the importance of protein engineering and molecular characterization in modern biomedical research. As the search for innovative solutions to complex diseases continues, the D266N recombinant protein serves as a valuable model for exploring the intricate relationships between genetic variations and pathophysiological outcomes.